
-
Lyles, Jefferson-Wooden storm to victories at US trials
-
De Minaur survives Tiafoe to reach Toronto quarter-finals
-
Young captures long-awaited first PGA Tour win at Wyndham Championship
-
Osaka roars into WTA Montreal quarter-finals as Keys fights through
-
West Ham blanks Bournemouth in Premier League US series
-
White's two homers drive Braves to 4-2 win over Reds in MLB Speedway Classic
-
Bolsonaro backers rally to praise Trump for Brazil pressure
-
Richardson exits 200m at US trials, Coleman through
-
Ferrari boss confident 'frustrated' Hamilton will bounce back after Hungarian GP
-
Chelsea sign Dutch defender Hato from Ajax
-
'Fantastic Four' stretches lead to 2nd week at N.America box office
-
Japan's Yamashita wins Women's British Open to clinch first major
-
Netanyahu asks ICRC for help after 'profound shock' of Gaza hostage videos
-
French rider Ferrand-Prevot solos to victory in women's Tour de France
-
Oval downpour leaves England-India series on knife edge
-
Despondent Hamilton and Ferrari crash back to earth
-
Norris relishing combat with McLaren teammate Piastri
-
US trade advisor says Trump tariff rates unlikely to change
-
Norris wins in Hungary to trim Piastri lead as McLaren reel off another 1-2
-
Norris wins Hungarian Grand Prix in another McLaren 1-2
-
Brook and Root run riot as England eye stunning win in India decider
-
Ukrainian drones spark fire at Sochi oil depot
-
Lando Norris wins Hungarian Grand Prix in another McLaren 1-2
-
Departing Spurs captain Son in tears on emotional evening
-
Marchand says 'passion' burns bright on road to 2028 Olympics
-
McIntosh says narrowly missing Phelps feat keeps her 'hungry' for LA
-
Eight OPEC+ countries raise production by 547,000 bpd
-
Marchand, McIntosh dominate as US end turbulent worlds with record
-
Marchand, McIntosh rampant as US end turbulent worlds with record
-
Olympic champ Finke slams 'stupid' criticism of US world swim team
-
Bangladesh protest victim gives evidence at ex-PM trial
-
McIntosh wins fourth Singapore gold with 400m medley title
-
Siraj strikes for India as England's Brook rides his luck in Oval thriller
-
Rovanpera delights home crowd with Rally of Finland victory
-
Tunisia's Jaouadi pushes through pain for second world gold
-
Australia's beaming Harris foils Walsh treble bid at swimming worlds
-
Pope's 'Jubilee of Youth' ends with mass for 1 million pilgrims
-
Pope's 'Jubilee of Youth' ends with Rome mass for 1 million pilgrims
-
Israel PM says in 'profound shock' over hostage videos
-
Pope's 'Jubilee of Youth' closes with huge Rome mass
-
Citroen 2CV lovers gather in Slovenia to take the slow road
-
Assange joins pro-Palestinian protest on Sydney Harbour Bridge
-
All Blacks scrum-half Roigard out of Argentina Tests
-
'Struggling' Marchand targets second gold at swimming worlds
-
Last-ball hero Holder lifts West Indies over Pakistan in T20
-
Chaos, gangs, gunfire: Gaza aid fails to reach most needy
-
Top seed Zverev, defending champ Popyrin book ATP Toronto quarter-final
-
Filmmakers try to cash in on India-Pakistan battle
-
Rain suspends MLB Speedway Classic until Sunday
-
Lions' Sheehan cited for foul play in third Wallabies Test
RBGPF | 0% | 74.94 | $ | |
VOD | 1.37% | 10.96 | $ | |
SCS | -1.47% | 10.18 | $ | |
GSK | 1.09% | 37.56 | $ | |
RYCEF | 0.07% | 14.19 | $ | |
RELX | -0.58% | 51.59 | $ | |
SCU | 0% | 12.72 | $ | |
NGG | 1.99% | 71.82 | $ | |
BTI | 1.23% | 54.35 | $ | |
CMSD | 0.34% | 23.35 | $ | |
RIO | -0.2% | 59.65 | $ | |
CMSC | 0.09% | 22.87 | $ | |
JRI | -0.23% | 13.1 | $ | |
AZN | 1.16% | 73.95 | $ | |
BCC | -0.55% | 83.35 | $ | |
BCE | 1.02% | 23.57 | $ | |
BP | -1.26% | 31.75 | $ |

Japanese researchers test pioneering drug to regrow teeth
People with missing teeth may be able to grow new ones, say Japanese dentists testing a pioneering drug they hope will offer an alternative to dentures and implants.
Unlike reptiles and fish, which usually replace their fangs on a regular basis, it is widely accepted that humans and most other mammals only grow two sets of teeth.
But hidden underneath our gums are the dormant buds of a third generation, according to Katsu Takahashi, head of oral surgery at the Medical Research Institute Kitano Hospital in Osaka.
His team launched clinical trials at Kyoto University Hospital in October, administering an experimental medicine to adult test subjects that they say has the potential to jumpstart the growth of these concealed teeth.
It's a technology "completely new" to the world, Takahashi told AFP.
Prosthetic treatments used for teeth lost to decay, disease or injury are often seen as costly and invasive.
So "restoring natural teeth definitely has its advantages", said Takahashi, the project's lead researcher.
Tests on mice and ferrets suggest that blocking a protein called USAG-1 can awaken the third set, and the researchers have published lab photographs of regrown animal teeth.
In a study published last year, the team said their "antibody treatment in mice is effective for tooth regeneration and can be a breakthrough in treating tooth anomalies in humans".
- 'Only the beginning' -
For now, the dentists are prioritising the "dire" needs of patients with six or more permanent teeth missing from birth.
The hereditary condition is said to affect around 0.1 percent of people, who can have severe trouble chewing, and in Japan often spend most of their adolescence wearing a face mask to hide the wide gaps in their mouth, Takahashi said.
"This drug could be a game-changer for them," he added.
The drug is therefore aimed primarily at children, and the researchers want to make it available as early as 2030.
Angray Kang, a dentistry professor at Queen Mary University of London, only knows of one other team pursuing a similar objective of using antibodies to regrow or repair teeth.
"I would say that the Takahashi group is leading the way," the immunotechnology expert, who is not connected to the Japanese research, told AFP.
Takahashi's work is "exciting and worth pursuing", Kang said, in part because an antibody drug that targets a protein nearly identical to USAG-1 is already being used to treat osteoporosis.
"The race to regenerate human teeth is not a short sprint, but by analogy a set of back-to-back consecutive ultra-marathons," he said.
"This is only the beginning."
Chengfei Zhang, a clinical professor in endodontics at the University of Hong Kong, said Takahashi's method is "innovative and holds potential".
"The assertion that humans possess latent tooth buds capable of producing a third set of teeth is both revolutionary and controversial," he told AFP.
He also cautioned that "outcomes observed in animals do not always directly translate to humans".
The results of the animal experiments raise "questions about whether regenerated teeth could functionally and aesthetically replace missing teeth", Zhang added.
- 'Over the moon' -
A confident Takahashi argues that the location of a new tooth in a mouth can be controlled, if not pinpointed, by the drug injection site.
And if it grows in the wrong place, it can be moved through orthodontics or transplantation, he said.
No young patients with the congenital disorder are taking part in the first clinical trial, as the main objective is to test the drug's safety, rather than its effectiveness.
So for now, the participants are healthy adults who have lost at least one existing tooth.
And while tooth regeneration is not the express goal of the trial this time around, there is a slim chance that it could happen to subjects anyway, Takahashi said.
If so, the researchers will have confirmed that the drug can be effective for those with acquired toothlessness -- which would be a medical triumph.
"I would be over the moon if that happens," Takahashi said.
This could be particularly welcome news in Japan, which has the second-oldest population in the world.
Health ministry data shows more than 90 percent of people aged 75 or older in Japan have at least one tooth missing.
"Expectations are high that our technology can directly extend their healthy life expectancy," Takahashi said.
S.AbuJamous--SF-PST